The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Biological Testing Facility Access For Contraceptive Development (X01 Clinical Trial Not Allowed)
The NICHD has a state-of-the art Biological Testing Facility for advancing male and/or female non-hormonal contraception development with the capabilities and capacity for preclinical and Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies (e.g., fertility studies, pharmacology, toxicology, reproductive tract histopathology, sperm morphology).
The purpose of this FOA is to provide investigators with a mechanism to request services from this facility that would advance their contraceptive development program.
- Letter of Intent Due Date(s): 30 days before application due date.
- Application Due Date(s): July 1, 2019, December 16, 2019, May 1, 2020
PAR-19-263 Expiration Date: May 02, 2020